President Trump’s threatened tariffs could lead to higher out-of-pocket costs or insurance premiums, depending on whether ...

For decades, the pharmaceutical industry has been defined by groundbreaking medical discoveries. But today, some of it ...

Using a non-GAAP industry average margin analysis of the short-run tariff impact, a 25% tariff would only amount to a ...

PRNewswire/ - NetraMark Holdings Inc. (the Company or NetraMark) (CSE: AIAI) (OTCQB: AINMF ) (Frankfurt: 8TV) </b ...

The president is expected to impose tariffs on pharmaceuticals, though full details of the plan have not yet been announced.

U.S. President Donald Trump late on Tuesday reiterated he would impose tariffs on imports of pharmaceutical products that ...

Swiss drugmaker Novartis said on Thursday it plans to spend $23 billion to build and expand 10 facilities in the U.S., as it ...

Swiss pharmaceutical giant Novartis said it plans to invest $23 billion in the construction and expansion of U.S. facilities, ...

Global drugmakers' stocks dropped across the board after US President Donald Trump reiterated plans for a "major" tariff on ...

Alex Kerr, UK economist at Capital Economics, said: “Based on the rise in gilt yields and the fall in interest rate ...

Products made here might still depend on materials from overseas. And they might be made on machines needing foreign replacement parts.

On the heels of similar investment pledges from Eli Lilly and Johnson & Johnson, Switzerland’s Novartis is stepping up to the ...